FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a pharmaceutical composition for local application containing a therapeutic compound of an immune response modifier, sterilisation-resistant and applicable for local application immediately on tissue regions with skin damages wherein said composition is sterilised by electron-beam irradiation, and the therapeutic compound represents 1-(2-methylpropyl)-1H-imidazo[4,5-c]quinoline-4-amine (imiquimod). Also, the invention refers to a packed composition for local application containing a packing material and said pharmaceutical composition.
EFFECT: invention provides the sterilisation-resistant pharmaceutical composition.
26 cl, 5 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| FOAM FORMULATION OF IMMUNE RESPONSE MODIFIER, METHOD FOR PREPARING BASED DRUG PREPARATION (VERSION) AND THERAPEUTIC KIT CONTAINING SAID FORMULATION | 2007 |
|
RU2481108C2 |
| COMPOSITIONS AND METHOD FOR TREATING DISEASED SKIN CONDITIONS | 2011 |
|
RU2578979C2 |
| INJECTION COMPOSITIONS BASED ON SESAME OIL | 2014 |
|
RU2687279C2 |
| COMPOSITIONS AND METHODS FOR TREATING CUTANEOUS T-CELL LYMPHOMA | 2014 |
|
RU2669941C2 |
| RESIQUIMOD DERIVATIVES | 2018 |
|
RU2808163C2 |
| PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PSORIASIS | 2020 |
|
RU2742879C1 |
| SYSTEMS AND METHODS OF MUCOSA SURFACE TREATMENT | 2001 |
|
RU2349321C2 |
| THERAPEUTIC AGENT FOR TREATMENT OF PRECANCEROUS SKIN LESIONS | 2004 |
|
RU2366447C2 |
| PHARMACEUTICAL CREAM COMPOSITION OF OXYMETAZOLINE FOR TREATING SYMPTOMS OF ROSACEA | 2012 |
|
RU2648439C2 |
| POCKET-PACKED PERSONAL HYGIENE COMPOSITION | 2004 |
|
RU2407510C2 |
